Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 4, 2003, Pages 881-890

  Kirklin, James K ^a,g   Naftel, D C ^a   Bourge, R C ^a   McGiffin, D C ^a   Hill, J A ^b   Rodeheffer, R J ^c   Jaski, B E ^d   Hauptman, P J ^e   Weston, M ^f   White Williams, C ^a   Blackstone, Eugene H ^h  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MAYO CLINIC   (United States)

^d SHARP MEMORIAL HOSPITAL   (United States)

^e SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^f TAMPA GENERAL HOSPITAL   (United States)

^g Kentucky   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; CRITICAL ILLNESS; DEVICE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; INOTROPISM; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SENSITIZATION; STATISTICAL ANALYSIS; SURVIVAL;

EID: 0037392332     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.168     Document Type: Article

References (9)

1. Bourge RC, Kirklin JK, Naftel DC, McGiffin DC. Predicting outcome after cardiac transplantations: lessons from the Cardiac Transplant Research Database. Curr Opin Cardiol. 1997;12:136-45.
2. Blackstone EH, Naftel DC, Turner ME. The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc. 1986;81:615-24.
3. McGiffin DC, Naftel DC, Kirklin JK, Morrow WR, Towbin J, Shaddy R, et al. Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. J Heart Lung Transplant. 1997; 16:713-22.
4. Kobashigawa JA, Miller L, Runlund D, Mentzer R, Alderman E, Bourge RC, et al. A randomized controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation. 1998;66:507-15.
5. Meiser BM, Kur F, Uberfuhr P, Reichenspurner H, Kreuzer E, Reichart B. Modern application for an old compound: 8-methoxypsoralen for photochemotherapy after heart transplantation. Transplant Proc. 1993;25:3307-8.
6. Meiser BM, Kur F, Reichenspurner H, Wagner F, Boos KS, Vielhauer S, et al. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation. Transplantation. 1994;57:563-8.
7. Mills RM, Naftel DC, Kirklin JK, VanBakel A, Jaski B, Massin E, et al. Heart transplant rejection with hemodynamic compromise: a multi-institutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant. 1994;16:813-21.
8. Ventura HO, Kirktin JK, Eisen H, Michler R, Clemson B. The combined impact of pretransplant risk factors and rejection frequency and severity on the prevalence of post transplant coronary vasculopathy. J Heart Lung Transplant. 1997;16.
9. Kirklin JK, Young JB, McGiffin DC. Heart transplantation. Philadelphia: Churchill Livingstone; 2001. p. 615-66.